Delivery Order SPE2DB24D1201-SPE2DR25F8QLR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Synthroid 137 micrograms, valued at $55,921.07, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,838.73 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 mcg in a quantity of 1,000 units. The contract was competitively awarded without set-aside restrictions under a firm fixed-price delivery order structure, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets (1,000 count) on July 22, 2025, with a ceiling value of $1,090.43. The contract employs firm fixed price pricing and is scheduled for ultimate completion by July 23, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $37,492.95 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 88 micrograms, a thyroid hormone replacement medication. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,786.70 on May 8, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order is set to be completed by May 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency Troop Support Medical awarded a $52,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 150 mcg Synthroid tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 6, 2023 under the terms of the order. The Defense Logistics Agency manages the Department of Defense's global supply chain and works...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Synthroid 50 mcg tablets. The $4,962.61 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DR25F8QLRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $52,854.31 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 mcg tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of pharmaceutical products and medical supplies to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to fulfill diverse medical supply requirements through open competition. Synthroid (levothyroxine), a thyroid hormone replacement medication, is a critical pharmaceutical commodity for treating hypothyroidism across military healthcare populations. This delivery order exemplifies the company's role as a key vendor within the DLA Medical Supply Chain, supporting the Defense Health Agency and other government healthcare systems with essential pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.9k | 8/21/25 |